Ear and kidney syndromes: Molecular versus clinical approach

Kidney International

Volumn 65, Issue 2, 2004, Pages 369-385

  Izzedine, Hassane ^a   Tankere, Frederic ^a   Launay Vacher, Vincent ^a   Deray, Gilbert ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTEGRIN; BETA1 INTEGRIN; BONE MORPHOGENETIC PROTEIN; FIBROBLAST GROWTH FACTOR; FRIZZLED PROTEIN; GENE PRODUCT; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; TRANSCRIPTION FACTOR FKHR; TRANSCRIPTION FACTOR GATA 3; WNT1 PROTEIN;

ALPORT SYNDROME; BARTTER SYNDROME; BRONCHIO OTO RENAL SYNDROME; CELL SUBPOPULATION; CHROMOSOME; CLINICAL FEATURE; DISEASE ACTIVITY; DISEASE ASSOCIATION; EAR MALFORMATION; EMBRYO DEVELOPMENT; EXTERNAL AUDITORY CANAL; FECHTNER SYNDROME; GENE EXPRESSION; GENE FUNCTION; GENETIC ASSOCIATION; GENETIC DISORDER; GLOMERULOPATHY; HEARING LOSS; HOMEOSTASIS; HUMAN; INNER EAR; KALLMANN SYNDROME; KIDNEY DEVELOPMENT; KIDNEY DYSPLASIA; KIDNEY MALFORMATION; KIDNEY TUBULE ACIDOSIS; KIDNEY TUBULE DISORDER; MIDDLE EAR; MITOCHONDRION; NONHUMAN; PENDRED SYNDROME; PERCEPTION DEAFNESS; PRIORITY JOURNAL; REVIEW; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION; SYNDROME; TOWNES BROCKS SYNDROME; URINARY TRACT MALFORMATION;

EID: 1642561731     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1523-1755.2004.00390.x     Document Type: Review

References (144)

1. POTTER EL: Bilateral renal agenesis. J Pediatr 29:68, 1946
2. KUGELMAN A, HADAD B, Ben-DAVID J, et al: Preauricular tags and pits in the newborn: the role of hearing tests. Acta Paediatr 86:170-172, 1997
3. KANKKUNEN A, THIRINGER K: Hearing impairment in connection with preauricular tags. Acta Paediatr Scand 76:143-146, 1987
4. STOLL C, WIESEL A, QUEISSER-LUFT A, et al: Evaluation of the prenatal diagnosis of limb reduction deficiencies. EUROSCAN Study Group. Prenat Diagn 20:811-818, 2000
5. KOHELET D, ARBEL E: A prospective search for urinary tract abnormalities in infants with isolated preauricular tags. Pediatrics 105:E61, 2000
6. LEUNG AK, ROBSON WL: Association of preauricular sinuses and renal anomalies. Urology 40:259-261, 1992
7. QUEISSER-LUFT A, STOLZ G, WIESEL A, et al: Association between renal malformations and abnormally formed ears: Analysis of 32,589 newborns and newborn fetuses of the Mainz Congenital Birth Defect Monitoring System, in XXI David W Smith Workshop on Malformation and Morphogenesis, San Diego, 2000, pp 60
8. KALATZIS V, SAHLY I, EL-AMRAOUI A, PETIT C: Eya1 expression in the developing ear and kidney: Towards the understanding of the pathogenesis of branchio-oto-renal (BOR) syndrome. Dev Dyn 213:486-499, 1998
9. GROVES AK, BRONNER-FRASER M: Competence, specification and commitment in otic placode induction. Development 127:3489-3499, 2000
10. HELLER N, BRANDLI AW: Xenopus Pax-2/5/8 orthologues: novel insights into Pax gene evolution and identification of Pax-8 as the earliest marker for otic and pronephric cell lineages. Dev Genet 24:208-219, 1999
11. PFEFFER PL, GERSTER T, LUN K, et al: Characterization of three novel members of the zebrafish Pax2/5/8 family: Dependency of Pax5 and Pax8 expression on the Pax2.1 (noi) function. Development 125:3063-3074, 1998
12. OHTO H, KAMADA S, TAGO K, et al: Cooperation of six and eya in activation of their target genes through nuclear translocation of Eya. Mol Cell Biol 19:6815-6824, 1999
13. ESTEVE P, BOVOLENTA P: cSix4, a member of the six gene family of transcription factors, is expressed during placode and somite development. Mech Dev 85:161-165, 1999
14. OZAKI H, YAMADA K, KOBAYASHI M, et al: Structure and chromosome mapping of the human SIX4 and murine Six4 genes. Cytogenet Cell Genet 87:108-112, 1999
15. KOBAYASHI M, OSANAI H, KAWAKAMI K, YAMAMOTO M: Expression of three zebrafish Six4 genes in the cranial sensory placodes and the developing somites. Mech Dev 98:151-155, 2000
16. GHANBARI H, SEO HC, FJOSE A, BRANDLI AW: Molecular cloning and embryonic expression of Xenopus Six homeobox genes. Mech Dev 101:271-277, 2001
17. BORSANI G, DEGRANDI A, BALLABIO A, et al: EYA4, a novel vertebrate gene related to Drosophila eyes absent. Hum Mol Genet 8:11-23, 1999
18. WAYNE S, ROBERTSON NG, DECLAU F, et al: Mutations in the transcriptional activator EYA4 cause late-onset deafness at the DFNA10 locus. Hum Mol Genet 10:195-200, 2001
19. HEANUE TA, RESHEF R, DAVIS RJ, et al: Synergistic regulation of vertebrate muscle development by Dach2, Eya2, and Six1, homologs of genes required for Drosophila eye formation. Genes Dev 13:3231-3243, 1999
20. VAINIO S, LIN Y: Coordinating early kidney development: Lessons from gene targeting. Nat Rev Genet 3:533-543, 2002
21. CANCILLA B, DAVIES A, CAUCHI JA, et al: Fibroblast growth factor receptors and their ligands in the adult rat kidney. Kidney Int 60:147-155, 2001
22. REPRESA J, LEON Y, MINER C, GIRALDEZ F: The int-2 proto-oncogene is responsible for induction of the inner ear. Nature 353:561-563, 1991
23. MANSOUR SL, GODDARD JM, CAPECCHI MR: Mice homozygous for a targeted disruption of the proto-oncogene int-2 have developmental defects in the tail and inner ear. Development 117:13-28, 1993
24. DODE C, LEVILLIERS J, DUPONT JM, et al: Loss-of-function mutations in FGFR1 cause autosomal dominant Kallmann syndrome. Nat Genet 33:463-465, 2003
25. MARTINEZ G, MISHINA Y, BERTRAM JF: BMPs and BMP receptors in mouse metanephric development: In vivo and in vitro studies. Int J Dev Biol 46:525-533, 2002
26. RAATIKAINEN-AHOKAS A, HYTONEN M, TENHUNEN A, et al: BMP-4 affects the differentiation of metanephric mesenchyme and reveals an early anterior-posterior axis of the embryonic kidney. Dev Dyn 217:146-158, 2000
27. CHANG W, TEN DIJKE P, WU DK: BMP pathways are involved in otic capsule formation and epithelial-mesenchymal signaling in the developing chicken inner ear. Dev Biol 251:380-394, 2002
28. SAULNIER DM, GHANBARI H, BRANDLI AW: Essential function of Wnt-4 for tubulogenesis in the Xenopus pronephric kidney. Dev Biol 248:13-28, 2002
29. SURENDRAN K, MCCAUL SP, SIMON TC: A role for Wnt-4 in renal fibrosis. Am J Physiol Renal Physiol 282: F431-F441, 2002
30. SHI DL, GOISSET C, BOUCAUT JC: Expression of Xfz3, a Xenopus frizzled family member, is restricted to the early nervous system. Mech Dev 70:35-47, 1998
31. DEARDORFF MA, KLEIN PS: Xenopus frizzled-2 is expressed highly in the developing eye, otic vesicle and somites. Mech Dev 87:229-233, 1999
32. MOLENAAR M, BRIAN E, ROOSE J, et al: Differential expression of the Groucho-related genes 4 and 5 during early development of Xenopus laevis. Mech Dev 91:311-315, 2000
33. STARK MR, RAO MS, SCHOENWOLF GC, et al: Frizzled-4 expression during chick kidney development. Mech Dev 98:121-125, 2000
34. DAUDET N, RIPOLL C, MOLES JP, REBILLARD G: Expression of members of Wnt and Frizzled gene families in the postnatal rat cochlea. Brain Res Mol Brain Res 105:98-107, 2002
35. VAN ESCH H, GROENEN P, NESBIT MA, et al: GATA3 haplo-insufficiency causes human HDR syndrome. Nature 406:419-422, 2000
36. RIVOLTA MN, HOLLEY MC: GATA3 is downregulated during hair cell differentiation in the mouse cochlea. J Neurocytol 27:637-647, 1998
37. KARIS A, PATA I, VAN DOORNINCK JH, et al: Transcription factor GATA-3 alters pathway selection of olivocochlear neurons and affects morphogenesis of the ear. J Comp Neurol 429:615-630, 2001
38. LAWOKO-KERALI G, RIVOLTA MN, HOLLEY M: Expression of the transcription factors GATA3 and Pax2 during development of the mammalian inner ear. J Comp Neurol 442:378-391, 2002
39. MULLER U, WANG D, DENDA S, et al: Integrin alpha-8/beta-1 is critically important for epithelial-mesenchymal interactions during kidney morphogenesis. Cell 88:603-613, 1997
40. EVANS AL, MULLER U: Stereocilia defects in the sensory hair cells of the inner ear in mice deficient in integrin alpha-8/beta-1. Nat Genet 24:424-428, 2000
41. HULANDER M, WURST W, CARLSSON P, ENERBACK S: The winged helix transcription factor Fkh10 is required for normal development of the inner ear. Nat Genet 20:374-376, 1998
42. PETERS TA, TONNAER EL, KUIJPERS W, et al: Differences in endolymphatic sac mitochondria-rich cells indicate specific functions. Laryngoscope 112:534-541, 2002
43. MIZUKAWA Y, NISHIZAVVA T, NAGAO T, et al: Cellular distribution of parchorin, a chloride intracellular channel-related protein, in various tissues. Am J Physiol Cell Physiol 282: C786-C795, 2002
44. ZHENG J, MADISON LD, OLIVER D, et al: Prestin, the motor protein of outer hair cells. Audiol Neurootol 7:9-12, 2002
45. DORNHOFFER JL, DANNER C, LI S: Natriuretic peptide receptors in the human endolymphatic sac. Arch Otolaryngol Head Neck Surg 128:379-383, 2002
46. MELNICK M, BIXLER D, SILK K, et al: Autosomal dominant branchiootorenal dysplasia. Birth Defects Orig Artic Ser 11:121-128, 1975
47. FRASER FC, SPROULE JR, HALAL F: Frequency of the branchio-oto-renal (BOR) syndrome in children with profound hearing loss. Am J Med Genet 7:341-349, 1980
48. FRASER FC, LING D, CLOGG D, NOGRADY B: Genetic aspects of the BOR syndrome - Brachial fistulas, ear pits, hearing loss, and renal anomalies. Am J Med Genet 2:241-252, 1978
49. MELNICK M, HODES ME, NANCE WE, et al: Branchio-oto-renal dysplasia and branchio-oto dysplasia: Two distinct autosomal dominant disorders. Clin Genet 13:425-442, 1978
50. CREMERS CW, FIKKERS-VAN NOORD M: The earpits-deafness syndrome. Clinical and genetic aspects. Int J Pediatr Otorhinolaryngol 2:309-322, 1980
51. HEIMLER A, LIEBER E: Branchio-oto-renal syndrome: Reduced penetrance and variable expressivity in four generations of a large kindred. Am J Med Genet 25:15-27, 1986
52. GIMSING S, DYRMOSE J: Branchio-oto-renal dysplasia in three families. Ann Otol Rhinol Laryngol 95:421-426, 1986
53. OSTRI B, JOHNSEN T, BERGMANN I: Temporal bone findings in a family with branchio-oto-renal syndrome (BOR). Clin Otolaryngol 16:163-167, 1991
54. KONIG R, FUCHS S, DUKIET C: Branchio-oto-renal (BOR) syndrome: Variable expressivity in a five-generation pedigree. Eur J Pediatr 153:446-450, 1994
55. DUMAS R, UZIEL A, BALDET P, SEGOND A: Glomerular lesions in the branchio-oto-renal (BOR) syndrome. Int J Pediatr Nephrol 3:67-70, 1982
56. CARMI R, BINSHTOCK M, ABELIOVICH D, BAR-ZIV J: The branchio-oto-renal (BOR) syndrome: Report of bilateral renal agenesis in three sibs. Am J Med Genet 14:625-627, 1983
57. CHEN A, FRANCIS M, NI L, et al: Phenotypic manifestations of branchio-oto-renal syndrome. Am J Med Genet 58:365-370, 1995
58. WEBER KM, KOUSSEFF BG: New manifestations of BOR syndrome. Clin Genet 56:306-312, 1999
59. KUMAR S, DEFFENBACHER K, MARRES HA, et al: Genomewide search and genetic localization of a second gene associated with autosomal dominant branchio-oto-renal syndrome: Clinical and genetic implications. Am J Hum Genet 66:1715-1720, 2000
60. KUMAR S, KIMBERLING WJ, KENYON JB, et al: Autosomal dominant branchio-oto-renal syndrome - Localization of a disease gene to chromosome 8q by linkage in a Dutch family. Hum Mol Genet 1:491-495, 1992
61. KUMAR S, KIMBERLING WJ, LANYI A, et al: Narrowing the genetic interval and yeast artificial chromosome map in the branchio-oto-renal region on chromosome 8q. Genomics 31:71-79, 1996
62. ABDELHAK S, KALATZIS V, HEILIG R, et al: A human homologue of the Drosophila eyes absent gene underlies branchio-oto-renal (BOR) syndrome and identifies a novel gene family. Nat Genet 15:157-164, 1997
63. ABDELHAK S, KALATZIS V, HEILIG R, et al: Clustering of mutations responsible for branchio-oto-renal (BOR) syndrome in the eyes absent homologous region (eyaHR) of EYA1. Hum Mol Genet 6:2247-2255, 1997
64. KUMAR S, MARRES HA, CREMERS CW, KIMBERLING WJ: Autosomal-dominant branchio-otic (BO) syndrome is not allelic to the branchio-oto-renal (BOR) gene at 8q13. Am J Med Genet 76:395-401, 1998
65. VINCENT C, KALATZIS V, ABDELHAK S, et al: BOR and BO syndromes are allelic defects of EYA1. Eur J Hum Genet 5:242-246, 1997
66. XU PX, ADAMS J, PETERS H, et al: Eya1-deficient mice lack ears and kidneys and show abnormal apoptosis of organ primordia. Nat Genet 23:113-117, 1999
67. KREIDBERG JA, SARIOLA H, LORING JM, et al: WT-1 is required for early kidney development. Cell 74:679-691, 1993
68. DURBEC P, Marcos-GUTIERREZ CV, KILKENNY C, et al: GDNF signalling through the Ret receptor tyrosine kinase. Nature 381:789-793, 1996
69. SANICOLA M, HESSION C, WORLEY D, et al: Glial cell line-derived neurotrophic factor-dependent RET activation can be mediated by two different cell-surface accessory proteins. Proc Natl Acad Sci USA 94:6238-6243, 1997
70. TRUPP M, ARENAS E, FAINZILBER M, et al: Functional receptor for GDNF encoded by the c-ret proto-oncogene. Nature 381:785-789, 1996
71. PACHNIS V, MANKOO B, COSTANTINI F: Expression of the c-ret proto-oncogene during mouse embryogenesis. Development 119:1005-1017, 1993
72. SCHUCHARDT A, D'AGATI V, LARSSON-BLOMBERG L, et al: Defects in the kidney and enteric nervous system of mice lacking the tyrosine kinase receptor Ret. Nature 367:380-383, 1994
73. BORSANI G, DEGRANDI A, BALLABIO A, et al: EYA4, a novel vertebrate gene related to Drosophila eyes absent. Hum Mol Genet 8:11-23, 1999
74. WAYNE S, ROBERTSON NG, DECLAU F, et al: Mutations in the transcriptional activator EYA4 cause late-onset deafness at the DFNA10 locus. Hum Mol Genet 10:195-200, 2001
75. TOWNES PL, BROCKS ER: Hereditary syndrome of imperforate anus with hand, foot, and ear anomalies. J Pediatr 81:321-326, 2000
76. POWELL CM, MICHAELIS RC: Townes-Brocks syndrome. J Med Genet 36:89-93, 1999
77. KURNIT DM, STEELE MW, PINSKY L, DIBBINS A: Autosomal dominant transmission of a syndrome of anal, ear, renal, and radial congenital malformations. J Pediatr 93:270-273, 1978
78. CAMERON TH, LACHIEWICZ AM, AYLSWORTH AS: Townes-Brocks syndrome in two mentally retarded youngsters. Am J Med Genet 41:1-4, 1991
79. ISHIKIRIYAMA S, KUDOH F, SHIMOJO N, et al: Townes-Brocks syndrome associated with mental retardation. Am J Med Genet 61:191-192, 1996
80. SURKA WS, KOHLHASE J, NEUNERT CE, et al: Unique family with Townes-Brocks syndrome, SALL1 mutation, and cardiac defects. Am J Med Genet 102:250-257, 2001
81. ROSSMILLER DR, PASIC TR: Hearing loss in Townes-Brocks syndrome. Otolaryngol Head Neck Surg 111:175-180, 1994
82. FERRAZ FG, NUNES L, FERRAZ ME, et al: Townes-Brocks syndrome. Report of a case and review of the literature. Ann Genet 32:120-123, 1989
83. DORAY B, LANGER B, STOLL C: Two cases of Townes-Brocks syndrome. Genet Couns 10:359-367, 1999
84. DE Vries-Van der WEERD MA, WILLEMS PJ, MANDEMA HM, TEN KATE LP: A new family with the Townes-Brocks syndrome. Clin Genet 34:195-200, 1988
85. NEWMAN WG, BRUNET MD, DONNAI D: Townes-Brocks syndrome presenting as end stage renal failure. Clin Dysmorphol 6:57-60, 1997
86. KOHLHASE J, WISCHERMANN A, REICHENBACH H, et al: Mutations in the SALL1 putative transcription factor gene cause Townes-Brocks syndrome. Nat Genet 18:81-83, 1998
87. KOHLHASE J, HEINRICH M, SCHUBERT L, et al: Okihiro syndrome is caused by SALL4 mutations. Hum Mol Genet 11:2979-2987, 2002
88. HARDELIN JP, JULLIARD AK, MONIOT B, et al: Anosmin-1 is a regionally restricted component of basement membranes and interstitial matrices during organogenesis: Implications for the developmental anomalies of X chromosome-linked Kallmann syndrome. Dev Dyn 215:26-44, 1999
89. DE MORSIER G: Etudes sur les dysraphies cranio-encephaliques. Schweiz Arch Neurol Psychiatr 74:309-361, 1954
90. HARDELIN JP, LEVILLIERS J, YOUNG J, et al: Xp22.3 deletions in isolated familial Kallmann's syndrome. J Clin Endocrinol Metab 76:827-831, 1993
91. HARDELIN JP, LEVILLIERS J, BLANCHARD S, et al: Heterogeneity in the mutations responsible for X chromosome-linked Kallmann syndrome. Hum Mol Genet 2:373-377, 1993
92. LIEBLICH JM, ROGOL AD, WHITE BJ, ROSEN SW: Syndrome of anosmia with hypogonadotropic hypogonadism (Kallmann syndrome): Clinical and laboratory studies in 23 cases. Am J Med 73:506-519, 1982
93. COATESWORTH AP, WOODHEAD CJ: Conductive hearing loss associated with Kallmann's syndrome. J Laryngol Otol 116:125-126, 2002
94. - reabsorption and inner ear K+ secretion. Nature 414:558-561, 2001
95. BIRKENHAGER R, OTTO E, SCHURMANN MJ, et al: Mutation of BSND causes Bartter syndrome with sensorineural deafness and kidney failure. Nat Genet 29:310-314, 2001
96. LIFTON RP: Molecular genetics of human blood pressure variation. Science 272:676-680, 1996
97. UCHIDA S, SASAKI S, NITTA K, et al: Localization and functional characterization of rat kidney-specific chloride channel, ClC-K1. J Clin Invest 95:104-113, 1995
98. KOBAYASHI K, UCHIDA S, MIZUTANI S, et al: Intrarenal and cellular localization of CLC-K2 protein in the mouse kidney. J Am Soc Nephrol 12:1327-1334, 2001
99. SIMON DB, BINDRA RS, MANSFIELD TA, et al: Mutations in the chloride channel gene, CLCNKB, cause Bartter's syndrome type III. Nat Genet 17:171-178, 1997
100. VANDEWALLE A, CLUZEAUD F, BENS M, et al: Localization and induction by dehydration of ClC-K chloride channels in the rat kidney. Am J Physiol 272:F678-F688, 1997
101. MATSUMURA Y, UCHIDA S, KONDO Y, et al: Overt nephrogenic diabetes insipidus in mice lacking the CLC-K1 chloride channel. Nat Genet 21:95-98, 1999
102. BRENNAN TM, LANDAU D, SHALEV H, et al: Linkage of infantile Bartter syndrome with sensorineural deafness to chromosome 1p. Am J Hum Genet 62:355-361, 1998
103. JECK N, REINALTER SC, HENNE T, et al: Hypokalemic salt-losing tubulopathy with chronic renal failure and sensorineural deafness. Pediatrics 108:E5, 2001
104. SIMON DB, NELSON-WILLIAMS C, et al: Gitelman's variant of Bartter's syndrome, inherited hypokalaemic alkalosis, is caused by mutations in the thiazide-sensitive Na-Cl cotransporter. Nat Genet 12:24-30, 1996
105. RUF R, RENSING C, TOPALOGLU R, et al: Confirmation of the ATP6B1 gene as responsible for distal renal tubular acidosis. Pediatr Nephrol 18:105-109, 2003
106. KARET FE, FINBERG KE, NELSON RD, et al: Mutations in the gene encoding B1 subunit of H(+)-ATPase cause renal tubular acidosis with sensorineural deafness. Nat Genet 21:84-90, 1999
107. SMITH AN, SKAUG J, CHOATE KA, et al: Mutations in ATP6N1B, encoding a new kidney vacuolar proton pump 116-kD subunit, cause recessive distal renal tubular acidosis with preserved hearing. Nat Genet 26:71-75, 2000
108. LYON MF, SCRIVE, CR, BAKER LRI, et al: The Gy mutation: Another cause of X-linked hypophosphatemia in mouse. Proc Natl Acad Sci 83:4899-4903, 1986
109. DAVIES M, KANE R, VALENTINE J: Impaired hearing in X-linked hypophosphataemic (vitamin-D-resistant) osteomalacia. Ann Intern Med 100:230-232, 1984
110. O'MALLEY S, RAMSDEN RT, LATIF A, et al: Electrocochleographic changes in the hearing loss associated with X-linked hypophosphataemic osteomalacia. Acta Otolaryng 100:13-18, 1985
111. WEIR N: Sensorineural deafness associated with recessive hypophosphataemic rickets. J Laryng Otol 91:717-722, 1977
112. LLOYD SE, PEARCE SHS, FISHER SE, et al: A common molecular basis for three inherited kidney stone diseases. Nature 370:445-449, 1996
113. STROM TM, FRANCIS F, LORENZ B, et al: Pex gene deletions in Gy and Hyp mice provide mouse models for X-linked hypophosphatemia. Hum Mol Genet 6:165-171, 1997
114. FLINTER F, BOBROW M: The molecular genetics of Alport syndrome: Report of two workshops. J Med Genet 29:352-353, 1992
115. GREGORY MC, TERREROS DA, BARKER DF, et al: Alport syndrome-clinical phenotypes, incidence, and pathology. Contrib Nephrol 117:1-28, 1996
116. ALPORT AC: Hereditary familial congenital haemorrhagic nephritis. Br Med J 1:504-506, 1927
117. BARKER DF, HOSTIKKA SL, ZHOU J, et al: Identification of mutations in the COL4A5 collagen gene in Alport syndrome. Science 248:1224-1227, 1990
118. MOCHIZUKI T, LEMMINK HH, MARIYAMA M, et al: Identification of mutations in the alpha 3(IV) and alpha 4(IV) collagen genes in autosomal recessive Alport syndrome. Nat Genet 8:77-81, 1994
119. KASHTAN CE, KIM Y: Distribution of the alpha 1 and alpha 2 chains of collagen IV and of collagens V and VI in Alport syndrome. Kidney Int 42:115-126, 1994
120. GUBLER MC, KNEBELMANN B, BEZIAU A, et al: Autosomal recessive Alport syndrome: Immunohistochemical study of type IV collagen chain distribution. Kidney Int 47:1142-1147, 1995
121. MAZZUCCO G, BARSOTTI P, MUDA AO, et al: Ultrastructural and immunohistochemical findings in Alport's syndrome: A study of 108 patients from 97 Italian families with particular emphasis on COL4A5 gene mutation correlations. J Am Soc Nephrol 9:1023-31, 1998
122. HARVEY SJ, MOUNT R, SADO Y, et al: The inner ear of dogs with X-linked nephritis provides clues to the pathogenesis of hearing loss in X-linked Alport syndrome. Am J Pathol 159:1097-1104, 2001
123. JEFFERSON JA, LEMMINK HH, HUGHES AE, et al: Autosomal dominant Alport syndrome linked to the type IV collagen alpha-3 and alpha-4 genes (COL4A3 and COL4A4). Nephrol Dial Transplant 12:1595-1599, 1997
124. VAN DER LOOP FT, HEIDET L, TIMMER ED, et al: Autosomal dominant Alport syndrome caused by a COL4A3 splice site mutation. Kidney Int 58:1870-1875, 2000
125. PETERSON LC, RAO KV, CROSSON JT, WHITE JG: Fechtner syndrome - A variant of Alport's syndrome with leukocyte inclusions and macrothrombocytopenia. Blood 65:397-406, 1985
126. GHIGGERI GM, CARIDI G, MAGRINI U, et al: Genetics, clinical and pathological features of glomerulonephritis associated with mutations of nonmuscle myosin IIA (Fechtner syndrome). Am J Kidney Dis 41:95-104, 2003
127. DELB W, SCHENK J, IRO H: Fechtner syndrome. A rare differential Alport syndrome diagnosis. HNO 48:616-620, 2000
128. MOXEY-MIMS MM, YOUNG G, SILVERMAN A, et al: End-stage renal disease in two pediatric patients with Fechtner syndrome. Pediatr Nephrol 13:782-786, 1999
129. PENDRED V: Deaf-mutism and goitre. Lancet II:532, 1896
130. COYLE B, COFFEY R, ARMOUR JAL, et al: Pendred syndrome (goitre and sensorineural hearing loss) maps to chromosome 7 in the region containing the nonsyndromic deafness gene DFNB4. Nat Genet 12:421-423, 1996
131. SHEFFIELD VC, KRAIEM Z, BECK JC, et al: Pendred syndrome maps to chromosome 7q21-34 and is caused by an intrinsic defect in thyroid iodineorganification. Nat Genet 12:424-426, 1996
132. EVERETT LA, GLASER B, BECK JC, et al: Pendred syndrome is caused by mutations in a putative sulphate transporter gene (PDS). Nat Genet 17:411-422, 1997
133. EVERETT LA, MORSLI H, WU DK, GREEN ED: Expression pattern of the mouse ortholog of the Pendred's syndrome gene (Pds) suggests a key role for pendrin in the inner ear. Proc Natl Acad Sci USA 96:9727-9732, 1999
134. - exchanger in the kidney cortex. Am J Physiol Renal Physiol 280:F356-F364, 2001
135. ROYAUX IE, WALL SM, KARNISKI LP, et al: Pendrin, encoded by the Pendred syndrome gene, resides in the apical region of renal intercalated cells and mediates bicarbonate secretion. Proc Natl Acad Sci USA 98:4221-4226, 2001
136. SCHULTHEIS PJ, CLARKE LL, MENETON P, et al: Renal and intestinal absorptive defects in mice lacking the NHE3 Na+/H+ exchanger. Nat Genet 19:282-285, 1998
137. ROBBINS J: KCNQ potassium channels: Physiology, pathophysiology, and pharmacology. Pharmacol Ther 90:1-19, 2001
138. BOETTGER T, HUBNER CA, MAIER H, et al: Deafness and renal tubular acidosis in mice lacking the K-Cl co-transporter Kcc4. Nature 416:874-878, 2002
139. NIELSEN S, FROKIAER J, MARPLES D, et al: Aquaporins in the kidney: From molecules to medicine. Physiol Rev 82:205-244, 2002
140. SAWADA S, TAKEDA T, KITANO H, et al: Aquaporin-2 regulation by vasopressin in the rat inner ear. Neuroreport 13:1127-1129, 2002
141. MORELLO JP, BICHET DG: Nephrogenic diabetes insipidus. Annu Rev Physiol 63:607-630, 2001
142. MARR N, BICHET DG, LONERGAN M, et al: Heteroligomerization of an aquaporin-2 mutant with wild-type aquaporin-2 and their misrouting to late endosomes/lysosomes explains dominant nephrogenic diabetes insipidus. Hum Mol Genet 11:779-789, 2002
143. MEYER Z, BALZ V, FELIX H: Mpv37 mouse strain-a model for the relationship between the kidney and the inner ear. Adv Otorhinolaryngol 59:84-90, 2002
144. MEYER ZUM GOTTESBERGE AM, REUTER A, WEIHER H: Inner ear defect similar to Alport's syndrome in the glomerulosclerosis mouse model Mpv17. Eur Arch Otorhinolaryngol 253:470-474, 1996